| 1. |
1. Okino, M. and Mohri, H. (1987) Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors.
Jpn. J. Cancer Res. 78, 1319–1321.
|
| |
| 2. |
2. Nishi, T., Yoshizato, K., Yamashiro, S., et al. (1996) High-efficiency in vivo gene transfer using intraarterial plasmid
DNA injection following in vivo electroporation. Cancer Res. 56, 1050–1055.
|
| |
| 3. |
3. Zhang, L., Li, L., Hofmann, G.A., and Hoffman, R.M. (1996) Depth-targeted efficient gene delivery and expression in the
skin by pulsed electric fields: an approach to gene therapy of skin aging and other diseases. Biochem. Biophys. Res. Commun. 220, 633–636.
|
| |
| 4. |
4. Heller, R., Jaroszeski, M., Atkin, A., et al. (1996) In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225–228.
|
| |
| 5. |
5. Li, S. (2004) Electroporation gene therapy: new developments in vivo and in vitro. Curr. Gene Ther. 4, 309–316.
|
| |
| 6. |
6. Liu, J., Xia, X., Torrero, M., Barrett, R., Shillitoe, E.J., and Li, S. (2006) The mechanism of exogenous B7.1-enhanced
IL-12-mediated complete regression of tumors by a single electroporation delivery. Int. J. Cancer. 119, 2113–2118.
|
| |
| 7. |
7. Jaroszeski, M.J., Heller, L.C., Gilbert, R., and Heller, R. (2004) Electrically mediated plasmid DNA delivery to solid
tumors in vivo. Methods Mol. Biol. 245, 237–244.
|
| |
| 8. |
8. Zhang, L., Widera, G., and Rabussay, D. (2004) Enhancement of the effectiveness of electroporation-augmented cutaneous
DNA vaccination by a particulate adjuvant. Bioelectrochemistry. 63, 369–373.
|
| |
| 9. |
9. Babiuk, S., Baca-Estrada, M.E., Foldvari, M., et al. (2003) Needle-free topical electroporation improves gene expression
from plasmids administered in porcine skin. Mol. Ther. 8, 992–998.
|
| |
| 10. |
10. Wolff, J.A. and Budker, V. (2005) The mechanism of naked DNA uptake and expression. Adv. Genet. 54, 3–20.
|
| |
| 11. |
11. Dev, N.B., Hofmann, G.A., Dev, S.B., and Rabussay, D.P. (2000) Intravascular electroporation markedly attenuates neointima
formation after balloon injury of the carotid artery in the rat. J. Intervent. Cardiol. 13, 331–338.
|
| |
| 12. |
12. Seidler, R.W., Allgauer, S., Ailinger, S., et al. (2005) In vivo human MCP-1 transfection in porcine arteries by intravascular
electroporation. Pharm. Res. 22, 1685–1691.
|
| |
| 13. |
http://www.cytopulse.scom/.
|
| |
| 14. |
14. Wallace, M.S., Ridgeway, B., Jun, E., Schulteis, G., Rabussay, D., and Zhang, L. (2001) Topical delivery of lidocaine
in healthy volunteers by electroporation, electroincorporation, or iontophoresis: an evaluation of skin anesthesia. Reg. Anesth. Pain Med. 26, 229–238.
|
| |
| 15. |
15. McCreery, T.P., Sweitzer, R.H., Unger, E.C., and Sullivan, S. (2004) DNA delivery in vivo by ultrasound. Methods Mol. Biol. 245, 293–298.
|
| |
| 16. |
16. Rabussay, D., Dev, N., Fewell, J., Smith, L.C., Widera, G., and Zhang, L. (2003) Enhancement of therapeutic drug and DNA
delivery into cells by electroporation. J. Phys. D: Appl. Phys. 36, 348–363.
|
| |
| 17. |
http://www.igea.it/.
|
| |
| 18. |
18. Tjelle, T.E., Salte, R., Mathiesen, I., and Kjeken, R. (2006) A novel electroporation device for gene delivery in large
animals and humans. Vaccine. 24, 4667–4670.
|
| |
| 19. |
http://www.ichorms.com/.
|
| |
| 20. |
http://www.advisys.net/.
|
| |
| 21. |
21. Hofmann, G.A., Rabussay, D., and Zhang, L. (2003) Method of electroporation-enhanced delivery of active agents. U.S. Patent 6,520,950.
|
| |
| 22. |
22. Rabussay, D.P., Nanda, G.S., and Goldfarb, P.M. (2002) Enhancing the effectiveness of drug-based cancer therapy by electroporation
(electropermeabilization). Technol. Cancer Res. Treat. 1, 71–82.
|
| |
| 23. |
23. Babiuk, S., Baca-Estrada, M.E., Foldvari, M., et al. (2004) Increased gene expression and inflammatory cell infiltration
caused by electroporation are both important for improving the efficacy of DNA vaccines. J. Biotechnol. 110, 1–10.
|
| |
| 24. |
24. Rabussay, D., Widera, G., Zhang, L., et al. (2004) Toward the development of electroporation for delivery of DNA vaccines
to humans. Mol. Ther. 9, S209.
|
| |
| 25. |
25. Prausnitz, M.R. (1996) The effects of electric current applied to skin: a review for transdermal drug delivery. Adv. Drug. Deliv. Rev. 18, 395–425.
|
| |
| 26. |
26. Domenge, C., Orlowski, S., Luboinski, B., et al. (1996) Antitumor electrochemotherapy: new advances in the clinical protocol.
Cancer. 77, 956–963.
|
| |
| 27. |
27. Mir, L.M., Belehradek, M., Domenge, C., et al. (1991) [Electrochemotherapy, a new antitumor treatment: first clinical
trial.] C.R. Acad. Sci. III. 313, 613–618.
|
| |
| 28. |
28. Heller, R., Jaroszeski, M.J., Glass, L.F., et al. (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous
tumors using electrochemotherapy. Cancer. 77, 964–971.
|
| |
| 29. |
29. Sersa, G., Cemazar, M., Semrov, D., and Miklavcic, D. (1996) Changing electrode orientation improves the efficacy of electrochemotherapy
of solid tumors in mice. Bioelectrochem. Bioenerg. 39, 61–66.
|
| |
| 30. |
30. Heller, L.C., Jaroszeski, M.J., Coppola, D., McCray, A.N., Hickey, J., and Heller, R. (2007) Optimization of cutaneous
electrically mediated plasmid DNA delivery using novel electrode. Gene Ther. 14, 275–280.
|
| |
| 31. |
31. Hofmann, G.A. (2000) Instrumentation and electrodes for in vivo electroporation. In: Jaroszeski, M.J., Heller, R. and
Gilbert, R. (eds.). Electrically mediated delivery of molecules to cells. Methods in molecular medicine, vol. 3. Humana, Totowa, NJ, pp. 37–61.
|
| |
| 32. |
32. Hofmann, G.A., Rabussay, D., and Tonnessen, A. (2001) Apparatus and method for the delivery of drugs and genes into tissue.
U.S. Patent 6,192, 270.
|
| |
| 33. |
33. Gilbert, R.A., Jaroszeski, M.J. and Heller, R. (1997) Novel electrode designs for electrochemotherapy. Biochim. Biophys. Acta. 1334, 9–14.
|
| |
| 34. |
34. Nuccitelli, R., Pliquett, U., Chen, X., et al. (2006) Nanosecond pulsed electric fields cause melanomas to self-destruct.
Biochem. Biophys. Res. Commun. 343, 351–360.
|
| |
| 35. |
35. Gehl, J. and Geertsen, P.F. (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy.
Melanoma Res. 10, 585–589.
|
| |
| 36. |
36. Oshima, Y., Sakamoto, T., Nakamura, T., et al. (1999) The comparative benefits of glaucoma filtering surgery with an electric-pulse
targeted drug delivery system demonstrated in an animal model. Ophthalmology. 106, 1140–1146.
|
| |
| 37. |
37. Bloquel, C., Bejjani, R., Bigey, P., et al. (2006) Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic
efficacy using hTNF-alpha soluble receptor in uveitis. FASEB J. 20, 389–391.
|
| |
| 38. |
38. Martin, J.B., Young, J.L., Benoit, J.N., and Dean, D.A. (2000) Gene transfer to intact mesenteric arteries by electroporation.
J. Vasc. Res. 37, 372–380.
|
| |
| 39. |
39. Davies, J.C. and Alton, E.W.F.W. (2005) Airway gene therapy. In: Hall, J. (ed.). Non-viral vectors for gene therapy (2nd edn.): Part 2. Advances in genetics, vol. 54. Elsevier, pp. 291–314.
|
| |
| 40. |
40. Machado-Aranda, D., Adir, Y., Young, J.L., et al. (2005) Gene transfer of the Na+, K+-ATPase beta1 subunit using electroporation
increases lung liquid clearance. Am. J. Respir. Crit. Care Med. 171, 204–211.
|
| |
| 41. |
41. Nikolski, V.P. and Efimov, I.R. (2005) Electroporation of the heart. Europace. 7, S146–S154.
|
| |
| 42. |
42. Hofmann, G.A. (2000) Electrporetic gene and drug therapy. U.S. Patent 6,132,419.
|
| |